Dr. Favret is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8613 Route 29
200
Fairfax, VA 22031Phone+1 571-350-8400Fax+1 703-940-8746
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1996 - 1999
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1993 - 1996
Lewis Katz School of Medicine at Temple UniversityClass of 1993
Certifications & Licensure
CA State Medical License 1996 - Present
VA State Medical License 1994 - 2026
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2) Start of enrollment: 2013 Dec 17
- Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC) Start of enrollment: 2017 Feb 02
Publications & Presentations
PubMed
- 13 citationsEfficacy and Safety of Ribociclib With Letrozole in US Patients Enrolled in the MONALEESA-2 Study.Denise A. Yardley, Lowell L. Hart, Anne Favret, Sibel Blau, Sami Diab
Clinical Breast Cancer. 2019-02-28 - 61 citationsRibociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trialGabe S. Sonke, Lowell L. Hart, Mario Campone, Frans L. G. Erdkamp, Wolfgang Janni
Breast Cancer Research and Treatment. 2018-02-01 - 1 citationsUse of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy in Early-Stage Invasive Breast Cancer.Joanne L. Blum, Nicholas J. Robert, Jay Andersen, Anne Favret, Patrick J. Ward
Journal of Clinical Oncology. 2017-12-11
Press Mentions
16 Physicians and Surgeons from Virginia Cancer Specialists Named as Virginia Business 2025 Top DoctorsFebruary 11th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
